88 related articles for article (PubMed ID: 8386483)
1. Ibutilide: enhanced defibrillation via plateau sodium current activation.
Wesley RC; Farkhani F; Morgan D; Zimmerman D
Am J Physiol; 1993 Apr; 264(4 Pt 2):H1269-74. PubMed ID: 8386483
[TBL] [Abstract][Full Text] [Related]
2. Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters.
Labhasetwar V; Underwood T; Heil RW; Gallagher M; Langberg J; Levy RJ
J Cardiovasc Pharmacol; 1994 Nov; 24(5):826-40. PubMed ID: 7532762
[TBL] [Abstract][Full Text] [Related]
3. Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model.
Zhang N; Luo Q; Jin Q; Han Y; Huang S; Wei Y; Lin C; Chen K; Shen W; Wu L
Cardiovasc Drugs Ther; 2020 Jun; 34(3):323-334. PubMed ID: 32297025
[TBL] [Abstract][Full Text] [Related]
4. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells.
Lee KS
J Pharmacol Exp Ther; 1992 Jul; 262(1):99-108. PubMed ID: 1320693
[TBL] [Abstract][Full Text] [Related]
5. Ionic mechanism of ibutilide in human atrium: evidence for a drug-induced Na+ current through a nifedipine inhibited inward channel.
Lee KS; Lee EW
J Pharmacol Exp Ther; 1998 Jul; 286(1):9-22. PubMed ID: 9655836
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
[TBL] [Abstract][Full Text] [Related]
7. Ibutilide decreases defibrillation threshold by the reduction of activation pattern complexity during ventricular fibrillation in canine hearts.
Jin Q; Zhou J; Zhang N; Lin CJ; Pang Y; Gu G; Shen WF; Wu LQ
Chin Med J (Engl); 2012 Aug; 125(15):2701-7. PubMed ID: 22931978
[TBL] [Abstract][Full Text] [Related]
8. Ibutilide for the control of refractory ventricular tachycardia and ventricular fibrillation in patients with myocardial ischemia and hemodynamic instability.
Sendra-Ferrer M; Gonzalez MD
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):503-510. PubMed ID: 30580467
[TBL] [Abstract][Full Text] [Related]
9. Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels.
Friedrichs GS; Chi L; Black SC; Manley PJ; Oh JY; Lucchesi BR
J Pharmacol Exp Ther; 1993 Sep; 266(3):1348-54. PubMed ID: 8371141
[TBL] [Abstract][Full Text] [Related]
10. The effect of newer antiarrhythmic drugs on defibrillation threshold.
Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA
Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635
[TBL] [Abstract][Full Text] [Related]
11. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide.
Buchanan LV; Kabell G; Turcotte UM; Brunden MN; Gibson JK
J Cardiovasc Pharmacol; 1992 Feb; 19(2):256-63. PubMed ID: 1376795
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance.
Ujhelyi MR; Schur M; Frede T; Bottorff MB; Gabel M; Markel ML
J Am Coll Cardiol; 1996 May; 27(6):1534-42. PubMed ID: 8626970
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart.
Pickoff AS; Stolfi A
Pacing Clin Electrophysiol; 2001 May; 24(5):816-23. PubMed ID: 11388101
[TBL] [Abstract][Full Text] [Related]
14. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs.
Babbs CF; Yim GK; Whistler SJ; Tacker WA; Geddes LA
Am Heart J; 1979 Sep; 98(3):345-50. PubMed ID: 157692
[TBL] [Abstract][Full Text] [Related]
15. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide.
Khoury DS; Assar MD; Sun H
J Interv Card Electrophysiol; 1997 Dec; 1(4):291-8. PubMed ID: 9869983
[TBL] [Abstract][Full Text] [Related]
17. Barium decreases defibrillation energy requirements.
Dorian P; Witkowski FX; Penkoske PA; Feder-Elituv RS
J Cardiovasc Pharmacol; 1994 Jan; 23(1):107-12. PubMed ID: 7511721
[TBL] [Abstract][Full Text] [Related]
18. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
Vereckei A; Gorski JC; Ujhelyi M; Mehra R; Zipes DP
Cardiovasc Drugs Ther; 2004 Jul; 18(4):269-77. PubMed ID: 15367824
[TBL] [Abstract][Full Text] [Related]
19. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
Mehdirad AA; Carnes CA; Nelson SD
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):147-51. PubMed ID: 9990620
[TBL] [Abstract][Full Text] [Related]
20. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization.
Nabih MA; Prcevski P; Fromm BS; Lavine SJ; Elnabtity M; Munir A; Steinman RT; Meissner MD; Lehmann MH
Pacing Clin Electrophysiol; 1993 Oct; 16(10):1975-83. PubMed ID: 7694244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
